Anatomic distribution of melanocytes in normal nail unit: An immunohistochemical investigation

American Journal of Dermatopathology

Volumn 19, Issue 5, 1997, Pages 462-467

  Perrin, Ch ^a,c   Michiels, J F ^a   Pisani, A ^b   Ortonne, J P ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Histology; Image analysis; Nail melanocytes

Indexed keywords

ARTICLE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; NAIL; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; CELL COUNT; CELL DIFFERENTIATION; COLORING AGENTS; DOPAMINE AGENTS; EPIDERMIS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEVODOPA; MALE; MELANINS; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NAIL DISEASES; NAILS; NEOPLASM PROTEINS; OXIDOREDUCTASES; PIGMENTATION DISORDERS; PROTEINS; VACUOLES;

EID: 0030711591     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199710000-00005     Document Type: Article

References (25)

1. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol 1989;21:1165-75.
2. Kopf AW, Waldo E. Melanonychia striata. Aust J Dermatol 1980;21:59-70.
3. Zaias M. Longitudinal pigmented bands. In: Zaias N, ed. The nail in health and disease, 2nd ed. Norwalk, CT: Appleton & Lange, 1990:229-33.
4. Higashi N. Melanocytes of nail matrix and nail pigmentation. Arch Dermatol 1968;97:570-4.
5. Eng AM, Vijaya B. Histologic expression of melanonychia. J Cutan Pathol 1992;19:520.
6. Molina D, Sanchez JL. Pigmented longitudinal bands of the nail. A clinicopathologic study. Am J Dermatopathol 1995;17:539-41.
7. Higashi N, Saito T. Horizontal distribution of the Dopa-positive metanocytes in the nail matrix. J Invest Dermatol 1969;53:163-5.
8. Tosti A, Cameli N, Piraccini BM, Fanti PA, Ortonne JP. Characterization of nail matrix melanocytes with anti-PEP1, anti-PEP8, TMH-1. and HMB-45 antibodies. J Am Acad Dermatol 1994;31:193-6.
9. Tomita Y, Shibahara S, Takeda A, Okinaga S, Matsunaga J, Tagami H. The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus. J Invest Dermatol 1991;96:500-4.
10. Wagner SN, Wagner C, Höfler H, Atkinson MJ, Goos M. Expression cloning of the cDNA encoding a melanoma-associated ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. Lab Invest 1995;73:229-35.
11. Kwon BS, Chintamaneni C, Kazak CA, et al. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 1991;88:9228-32.
12. Schaumburg-Lever G, Metzler G, Kaiserling E. Ultrastructural location of HMB45 binding sites. J Cutan Pathol 1991;18:432-5.
13. Kapur RP, Bigler SA, Skelly M, Gown AM. Antimelanoma antibody HMB45 identifies on oncofectal glycoconjugate associated with immature melanosome. J Histochem Cytochem 1992;40:207-12.
14. Orlow SJ, Boissy RE, Moran DJ, Pifko-Hirst SP. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis. J Invest Dermatol 1993;100:55-64.
15. Hashimoto K. Ultrastructure of the human toenail. Proximal nail matrix. J Invest Dermatol 1971;56:235-46.
16. Fechner GA, Parsons PG, McEwan MT, Jacob JJ, Takahashi M. Antiproliferative and depigmenting effects of histamine (H2) against Dimapret and derivatives on human melanoma cells. Bioderm Pharmacol 1992;43:2083-90.
17. McEwan MT, Parsons PG, Moss DJ. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells. J Invest Dermatol 1988;90:515-9.
18. McEwan MT, Parsons PG, Moss DJ, et al. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells. Pigment Cell Res 1989;2:1-7.
19. Starrico RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of adult human epidermis. J Invest Dermatol 1957;28:33-43.
20. Dawber RPR, De Berker D, Baran R. Science of the nail apparatus: In: Baran R and Dawber RPR, eds. Diseases of the nail and their management, 2nd ed. Oxford: Blackwell Scientific, 1994:6-7.
21. Walters DS, Scher RK. Nail terminology. Int J Dermatol 1995;34:607-10.
22. Horikawa T, Morris DA, Johnson TW, et al. Dopa-negative melanocytes in the outer root sheath of human fair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP2. J Invest Dermatol 1996;106:28-35.
23. Adema GJ, de Boer AJ, Vogel AM, Loenen WAM, Figdor CG. Molecular characterization of the melanocyte lineage-specific antigen gp 100. J Biol Chem 1994;269:20126-33.
24. Leyden JJ, Spot DA, Goldsmith H. Diffuse and banded melanin pigmentation in nails. Arch Dermatol 1972;105:548-50.
25. Baran R, Perrin C. Pseudo-fibrokeratoma of the nail apparatus with melanocytic pigmentation. Acta Derm Venereol (Stockh) 1994;74:449-50.